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Abstract
Background: Approximately two thirds of patients with irritable bowel syndrome (IBS) respond well to
hypnotherapy. However, it is time consuming as well as expensive to provide and therefore a way of predicting
outcome would be extremely useful. The use of imagery and color form an integral part of the hypnotherapeutic
process and we have hypothesised that investigating color and how it relates to mood might help to predict
response to treatment. In order to undertake this study we have previously developed and validated a method of
presenting colors to individuals for research purposes called the Manchester Color Wheel (MCW). Using this
instrument we have been able to classify colors into positive, neutral and negative shades and this study aimed to
assess their predictive role in hypnotherapy.
Methods: 156 consecutive IBS patients (aged 14-74, mean 42.0 years, 127 (81%) females, 29 (19%) males) were
studied. Before treatment, each patient was asked to relate their mood to a color on the MCW as well as
completing the IBS Symptom Severity Score, the Hospital Anxiety and Depression (HAD) Scale, the Non-colonic
Symptom Scale, the Quality of Life Scale and the Tellegen Absorption Scale (TAS) which is a measure of
hypnotisability. Following hypnotherapy all these measures were repeated with the exception of the TAS.
Results: For patients with a positive mood color the odds of responding to hypnotherapy were nine times higher
than that of those choosing either a neutral or negative color or no color at all (odds ratio: 8.889; p = 0.042).
Furthermore, a high TAS score and the presence of HAD anxiety also had good predictive value (odds ratio: 4.024;
p = 0.092, 3.917; p < 0.001 respectively) with these markers and a positive mood color being independent of each
other. In addition, these factors could be combined to give an even stronger prediction of outcome. Twice as
many responders (63, 77.8%) had a positive mood color or were anxious or had a high TAS score compared with
32 (42.7%) without these factors (p < 0.001).
Conclusion: A positive mood color, especially when combined with HAD anxiety and a high TAS score, predict a
good response to hypnotherapy.
Background
We have previously shown that patients with irritable
bowel syndrome (IBS) are more likely to respond to
hypnotherapy (HT) treatment if they have an image of
their illness and especially if that image is in color [1].
This led us to speculate that how a patient relates their
illness and their mood to color might also help to pre-
dict outcome to treatment and it was the purpose of
this study to test this hypothesis. In the absence of a
simple way of presenting a series of colors to a patient
for choice it was necessary to create a suitable instru-
ment (Figure 1) which we called the Manchester Color
Wheel (MCW) [2]. The development and validation of
the MCW is described elsewhere and using this instru-
ment it emerged that the positive, neutral and negative
attributions of color appeared to be much more mean-
ingful in relation to mood than an individual color itself.
This was because different shades of the same color
could have completely different connotations, for
instance, pale blue was strongly positive whereas dark
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research on color it may be more useful to relate find-
ings to whether color choice is collectively positive or
negative rather than concentrating on a particular color
[2].
Data on color perception and mood suggests that
black, brown and grey are consistently associated with
negative emotions [3,4] and it has been shown that
patients suffering from depression appear to have
impaired color sensitivity [5] and view life monochroma-
tically [6]. It has also been shown that depressed sub-
jects are more likely to choose brown and black to
describe their current mood whereas non-depressed
individuals are more likely to choose colors which
reflect their color preference [7]. Similarly, we have
shown, using the MCW, that negative colors are more
likely to be chosen by depressed subjects and that in
most cases the higher the depression score the more
likely they are to choose such a color. In addition we
have found that up to 79% of people with an affective
disorder equate their mood with a color compared to
only 39% of healthy controls [2]. Thus, if an individual
has something that affects their mood this makes them
more likely to attribute a color to their state of mind.
This study aimed to assess whether hypnotherapeutic
outcome could be predicted by relating mood to a posi-
tive, neutral or negative color (Figure 2) as well as seek-
ing an association, if any, with symptom severity,
hypnotisability or anxiety and depression.
Methods
156 consecutive patients (aged 14-74, mean 42.0 years,
127 (81%) females, 29 (19%) males) attending the Hyp-
notherapy Unit at Wythenshawe Hospital who fulfilled
the Rome II criteria [8] for IBS were studied. Non-colo-
nic symptoms are a prominent and intrusive feature of
IBS [9] and were recorded in addition to all the classic
symptoms of IBS. Patients suffering from any significant
psychiatric disease or any other serious concomitant dis-
ease such as diabetes or heart disease were also
excluded from the study as were individuals with color
blindness and pregnant women.
Prior to consultation with the hypnotherapist, using
the MCW [2], each patient was asked, “With regard to
your day-to-day mood over the last few months, do you
associate it with a particular color? If so, which color?”
In addition, the validated Symptom Severity Question-
naire [10] was also completed, with a reduction in score
Please
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Figure 1 The Manchester Color Wheel.
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Page 2 of 9of greater than 50 points being considered as clinically
significant. The Hospital Anxiety and Depression (HAD)
Scale [11] was also administered with a score of 10 or
more for either anxiety or depression being regarded as
abnormal. The Non-colonicS y m p t o mS c a l e[ 1 2 ] ,a n d
Quality of Life Scale [12] were then completed as well
as the Tellegen Absorption Scale (TAS) [13], which is
used to assess hypnotisability in terms of high, medium
or low. The patients then attended for 12 sessions of
‘gut-focused’ HT [14], over a three-month period,
usually at weekly intervals. They were then asked to
evaluate the change in their symptoms, in percentage
terms compared with how they were before the start of
therapy. A responder was defined as an individual who
experienced a 50% or more reduction in their overall
symptoms of their IBS following treatment. Patients also
repeated the IBS Symptom Severity Questionnaire, the
HAD Scale, the Non-colonic Symptom Scale, and Qual-
ity of Life Scale and were again asked, “With regard to
your day-to-day mood over the last few months, do you
associate it with a particular color? If so, which color?”
The main objective of this study was to ascertain
whether color choice could predict a good or poor out-
come for patients undergoing HT for their IBS. In order
to achieve this, the response rate was assessed in rela-
tion to their positive, neutral and negative color choices
as well as those who chose no color at all (’none’). The
data were analysed on an intention-to-treat basis in
order to establish whether patients who failed to start or
complete treatment had any particular characteristics
with regard to their color choice.
Statistical analysis
The statistical package SPSS 15 was used for analysing
the data. Parametric tests were used for the Normally
distributed data. The distribution of data was assessed
by calculating skewness and kurtosis statistics. The Pear-
son Chi-squared test was used to assess relationships
between categorical variables and the Fisher’s Exact test
where the volunteer numbers were small. Linear-by-lin-
ear associations were used to assess the linear trend
across the three classifications of hypnotic ability of the
TAS. Analysis of differences between multiple groups
was carried out using one-way ANOVA, with Scheffé’s
[15] multiple comparison Post-hoc test. Logistic regres-
sion was carried out to assess whether mood color, TAS
score and HAD score had an independent relationship
with response to treatment or whether one of these fac-
tors was acting as a proxy for another. It should be
noted that where patient numbers were relatively small,
the statistical analysis needs to be regarded as explora-
tory rather than definitive. The results did show a firm
trend and therefore the application of a Bonferonni cor-
rection was thought to be unnecessary.
Ethical approval was sought and obtained from South
Manchester Research Ethics Committee and all subjects
gave written consent before participating.
Results
Of the 156 patients included in this study 95 (60.9%)
responded to treatment, 41 (26.3%) were non-respon-
ders and 20 (12.8%) failed to start or complete treat-
ment. With respect to the symptom severity score,
responders exhibited a mean reduction of 146.
1 2 3 4 9 10
11
5 8
37 38
13 14
15 16 21
22 23 24
17
19 20
25
26 27
28 33 34 35 36 29
30 31 32
12
6 7
18
Positive Neutral Negative
Figure 2 Classification of colors from the MCW into positive, neutral and negative shades [2].
Table 1 Response to hypnotherapy and mood color
choice (pre-HT)
Positive
No. (%)
Neutral
No. (%)
Negative
No. (%)
None
No. (%)
Responders (n = 95) 12 (12.6%) 23 (24.2%) 20 (21.1%) 40 (42.1%)
Non-responders
& non-finishers
(n = 61)
1 (1.6%) 8 (13.1%) 19 (31.1%) 33 (54.1%)
Chi-square (3) = 10.344; p = 0.016
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The color choice of patients pre-HT is shown in Table
1. As can be seen, 36.8% of responders (p = 0.003, Fish-
er’s Exact test) associated a positive or neutral color
with their mood as opposed to 14.7% of non-responders
and non-finishers. In contrast, 85.2% of non-responders
and non-finishers associated a negative color or no
color at all with their mood compared with 63.2% of the
responder group. When comparing positive color choice
with neutral, negative and ‘none’ combined the differ-
ence was also statistically significant (p = 0.016, Fisher’s
Exact test).
Anxiety and depression
The above results were then re-analysed to see
whether there were any differences between mood
color choice and response to HT when patients were
divided into those suffering from anxiety and depres-
sion according to the HAD Scale as well as those who
were neither anxious nor depressed. Analyses were
carried out by comparing the positive color group
with the neutral, negative and ‘none’ groups combined
and the results are shown in Table 2. As can be seen,
the main differences were that non-responders consis-
tently failed to choose a positive color to describe
their mood irrespective of whether they were HAD
normal, anxious or depressed. In addition, depressed
individuals also failed to choose a positive color to
describe their mood and were more likely to choose a
negative color irrespective of whether they responded
or not.
Associations of mood color with Hospital Anxiety and
Depression (HAD) score, Tellegen Absorption Scale (TAS)
score, symptom severity, non-colonic symptomatology
and quality of life, pre-hypnotherapy (pre-HT)
Hospital Anxiety and Depression (HAD) score (pre-HT)
The actual mean scores for anxiety and depression were
also related to pre-HT mood color choice groupings
(positive, neutral and negative), irrespective of response
to treatment, using ANOVA (Table 3). Multiple com-
parisons were carried out using the Scheffé Post-hoc
test on the same data. As can be seen there was a signif-
icant association between anxiety (p = 0.036) and
depression (p < 0.001) scores and color choice group-
ings. Patients who chose negative colors were more
likely to have higher anxiety and depression scores. In
contrast, patients who chose positive colors were more
likely to have lower anxiety and depression scores. Post-
hoc tests revealed a trend towards significance between
the positive and negative groups (p = 0.91) for anxiety.
With regard to depression, statistical differences were
found between the positive and negative (p < 0.001) and
neutral and negative (p = 0.001) groups.
Tellegen Absorption Scale (TAS) score (pre-HT)
Patients scoring between 26-34 points on the TAS were
classed as having a high hypnotic ability, between 16-25
medium and between 0-15 points low hypnotic ability.
There was a significant association between the two
mood color groups (positive versus neutral, negative and
no color choice combined) and TAS scores in that those
w i t hah i g h e rT A Ss c o r ew e r em o r el i k e l yt oc h o o s e
positive colors compared with those with lower scores
(Table 4). Two patients out of a total of 156 failed to
complete the TAS questionnaire satisfactorily and had
to be omitted from the analysis.
Symptom Severity, Non-colonic Symptoms and Quality of
Life (pre-HT)
Mood color was not significantly associated with symp-
tom severity or the non-colonic symptoms. However,
there was a significant association with quality of life.
Table 5 describes the association with mood color in
more detail showing that patients who chose negative
colors were more likely to have a poorer quality of life
(p = 0.008). Post-hoc tests revealed a significant differ-
ence between the positive and negative groups (p =
0.041) and the neutral and negative groups (p = 0.033).
Associations of mood color with Hospital Anxiety and
Depression (HAD) score, Tellegen Absorption Scale (TAS)
score, symptom severity, non-colonic symptomatology
and quality of life, post-hypnotherapy (post-HT)
Hospital Anxiety and Depression (HAD) score (post-HT)
ANOVA was used to compare the post-HT values
of anxiety and depression and the individual color
Table 2 Response to hypnotherapy and mood color
choice in ‘HAD normal’, ‘HAD anxious’ and ‘HAD
depressed’ patients (pre-HT)
Positive
No. (%)
Neutral
No. (%)
Negative
No. (%)
None
No. (%)
’HAD normal’ (n = 52)
Responders (n = 26) 6 (23.1%) 6 (23.1%) 4 (15.4%) 10 (38.5%)
Non-responders
& non-finishers (n = 26)
0 (0%) 6 (23.1%) 4 (15.4%) 16 (61.5%)
’HAD anxious’ (n = 67)
Responders (n = 52) 6 (11.5%) 14 (26.9%) 10 (19.2%) 22 (42.3%)
Non-responders
& non-finishers
(n = 15)
0 (0%) 1 (6.7%) 3 (20.0%) 11 (73.3%)
’HAD depressed’ (n = 35)
Responders (n = 17) 0 (0%) 3 (17.6%) 6 (35.3%) 8 (47.1%)
Non-responders
& non-finishers
(n = 18)
1 (5.6%) 1 (5.6%) 11 (61.1%) 5 (27.8%)
Fisher’s Exact Test: Positive versus neutral, negative and none combined
’HAD normal’ p = 0.023; ‘HAD anxious’ p = 0.33; ‘HAD depressed’ p = 1.0
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regard to post-HT mood color. Multiple comparisons
were carried out using the Scheffé Post-hoc test on the
same data.
There was a significant association between depression
scores and the color choice with regard to mood color
(p = 0.015) although not with anxiety (p = 0.27). Table
6 describes the association with depression in more
detail showing that patients who chose negative colors
were more likely to have higher depression scores. Post-
hoc tests revealed that there was a statistically signifi-
cant difference between the positive and negative groups
(p = 0.023).
Symptom Severity, Non-colonic Symptoms and Quality of
Life (post-HT)
There was a significant relationship between the post-HT
symptom severity, the non-colonic and quality of life
scores and mood color (p = 0.013, p = 0.024, p = 0.014
respectively). Table 7 describes these associations in more
detail showing that patients who chose negative colors
were more likely to have higher symptom severity scores,
higher non-colonic scoresa n dw o r s eq u a l i t yo fl i f e
whereas patients who chose positive colors had lower
symptom severity scores and better quality of life. Post-
hoc tests revealed significant differences between the
positive and negative groups for symptom severity, non-
colonic score and quality of life (p = 0.018, p = 0.029, p
= 0.020 respectively). Furthermore, there was also a sig-
nificant difference between the neutral and negative
groups with respect to the non-colonic symptom score
(p = 0.042).
Predictive value of color choice
As already described, mood color had predictive value
with regard to response to treatment (Table 1). It was
considered that other factors such as anxiety, depres-
sion or absorption might also have an effect. Conse-
quently a univariate analysis was undertaken to
establish the effect, if any, of these variables. The
results are shown in Table 8 and, as can be seen, TAS
s c o r ea n dH A Da n x i e t ys c o r ew e r es i g n i f i c a n tp r e d i c -
tors of response to HT treatment (p = 0.008 and p =
0.002 respectively).
Logistic regression was carried out in order to assess
whether these factors, as well as mood color, had an
independent relationship with response to treatment or
whether one factor was acting as a proxy for another, in
other words, these predictive factors were interrelated.
Table 9 confirms that each of these factors had a signifi-
cant independent relationship with response to treat-
ment, with the TAS score showing less evidence of
predictive power. For patients with a positive mood
color the odds of responding to HT were nearly nine
times higher than that of those choosing either a neutral
or negative color or no color at all. Furthermore, for
patients who were anxious or had a high TAS score, the
odds of responding were approximately four times
higher compared to the reference groups.
Further analysis was undertaken to establish the pre-
dictive value of having one of the markers described in
Table 3 Association between pre-HT anxiety and depression score and pre-HT mood color choice
95% confidence interval
Mood color (n = 82) Mean score Lower limit Upper limit p value
Anxiety
Positive (n = 13) 10.31 8.52 12.09 ANOVA:
f (2,79) = 3.476; p = 0.036
Neutral (n = 31) 11.23 9.64 12.81
Negative (n = 38) 13.45 11.86 15.04
Depression
Positive (n = 13) 4.62 2.83 6.40 ANOVA:
f (2,79) = 12.287; p < 0.001
Neutral (n = 31) 5.87 4.82 6.92
Negative (n = 38) 9.13 7.85 10.41
Out of a total of 156 patients, one patient failed to complete the HAD questionnaire satisfactorily and had to be omitted from the analysis and 73 patients chose no
color at all.
Table 4 Association between TAS score (hypnotic ability) and mood color choice
Mood color (n = 154) TAS score p value
High Medium Low
Positive (n = 13) 2 (16.7%) 8 (12.5%) 3 (3.8%) Linear trend: Chi-square (1) = 4.353; p = 0.037
’Others’ (n = 141) 10 (83.3%) 56 (87.5%) 75 (96.2%)
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many responders (63, 77.8%) were either anxious or had
a high TAS score or chose a positive color to describe
their mood, compared with 32 (42.7%) without any of
these features (Chi-square (1) = 20.161; p < 0.001).
Furthermore, the presence of two or more of these mar-
kers guaranteed a response to treatment (p = 0.007,
Fisher’s Exact test).
Discussion
This study has established that color choice helps to
predict response to HT. For patients relating their mood
to a positive mood color, the odds of responding to HT
were nearly nine times higher than that of those choos-
ing either a neutral or negative color or no color at all.
HAD anxiety and a high TAS score were also found to
be useful factors in determining a good response to
treatment.
Our Unit has been providing HT for the treatment of
IBS for over twenty years with approximately two thirds
of patients responding to treatment [16]. Unfortunately,
patients may require as many as twelve one hour ses-
sions of therapy to secure a response and consequently
this results in the treatment being relatively expensive to
provide. It would therefore be extremely useful if there
were a way of predicting those who would or would not
respond to treatment. If a sufficiently robust way of sin-
gling out potential responders could be identified this
would save the third of individuals who fail to respond,
the disappointment of going through unsuccessful HT.
This group could then be offered some alternative man-
agement strategy.
Imagery plays an important part in the hypnothera-
peutic process and we have previously shown that
patients, who have an image of their disorder, especially
if it is in color, are more likely to respond to this parti-
cular form of treatment [1]. However, the predictive
value of having an image is not exact and therefore
additional measures are necessary. We therefore
hypothesised that how a patient relates to color might
have additional value in defining a responder. In a pilot
study we assessed mood color, favourite color, drawn to
color and color of illness and found that only mood
color appeared to have potential for the purposes of this
study.
In the present study the response rate to HT was 61%
which is slightly lower than we have previously observed
[16]. This is because we included patients who did not
even start treatment following consultation with the
hypnotherapist as we wanted to try and define the char-
acteristics of patients who were clearly unsuited to this
form of treatment from the outset. In addition to the
clear cut relationship of a positive mood color, HAD
anxiety and a high TAS score with a good hypnothera-
peutic outcome, there were a number of other signifi-
cant observations of interest. For instance before HT,
even if responders did not choose a positive color, they
significantly associated their mood with a neutral color
as opposed to non-responders and non-finishers who
chose negative colors or no color to describe their
mood (p = 0.016). Furthermore, if a patient chose a
positive color to describe their mood and had a normal
HAD score they were even more likely to respond.
Interestingly, 23% of ‘HAD normal’ and 12% of ‘HAD
anxious’ responders chose a positive color to describe
their mood compared with none of the ‘HAD depressed’
responders. In contrast, only one patient in the non-
responder group chose a positive shade. Gender
appeared to have little effect on any of the results.
Table 5 Association between pre-HT quality of life score and pre-HT mood color choice
Mood color (n = 82) Mean score 95% confidence interval p value
Lower limit Upper limit
Positive (n = 13) 216.23 175.81 256.65 ANOVA:
f (2,79) = 5.137; p = 0.008
Neutral (n = 31) 231.03 207.57 254.49
Negative (n = 38) 283.58 251.75 315.41
Out of a total of 156 patients, one patient failed to complete the quality of life questionnaire satisfactorily and had to be omitted from the analysis and 73 patients
chose no color at all.
Table 6 Association between post-HT depression score and post-HT mood color choice
Mood color (n = 87) Mean score 95% confidence interval p value
Lower limit Upper limit
Positive (n = 53) 3.53 2.53 4.53 ANOVA:
f (2,84) = 4.418; p = 0.015
Neutral (n = 26) 4.96 3.49 6.44
Negative (n = 8) 7.75 2.32 13.18
Out of a total of 156 patients, 20 were non-finishers and 49 patients chose no color at all.
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depression are very unlikely to choose a positive shade
to describe their mood [2]. Consequently, it might be
concluded that, as a positive shade is a predictor of a
good outcome with HT, IBS patients exhibiting depres-
s i o nc o u l db ed e e m e da su n s u i t a b l ef o rt h i sf o r mo f
treatment because they are likely to choose a negative
color. However, this analysis has shown that the
depressed patients who responded to HT had comple-
tely different characteristics to depressed non-respon-
ders. Firstly, fewer selected a negative color and this
could be interpreted as either they are not so
entrenched in their depression or that they differ from
endogenously depressed patients in that they are
depressed because of their illness, rather than just being
depressed and this is easier to manage. Another charac-
t e r i s t i cw a st h a tt h e yw e r em o r el i k e l yt oc h o o s ea
neutral color or no color at all and this could be inter-
preted as meaning that their depression was not so
‘dark’ indicating the ability to see a way out of their con-
dition. Therefore, in depressed IBS patients being con-
sidered for HT, those choosing neutral colors or no
color at all to describe their mood should certainly not
be excluded from being given the opportunity to receive
this form of treatment.
Patients with high TAS scores were more likely to
choose positive shades in relation to mood colors. Con-
versely, those with medium or low scores more fre-
quently selected a neutral or negative color or no color
at all. This might be explained by the fact that the TAS
questionnaire is, in some ways, a test of the imagination
which is an important component of hypnotic ability.
Therefore individuals scoring highly on such an instru-
ment might be expected to more easily give answers in
Table 7 Association between post-HT symptom severity, non-colonic and quality of life scores and post-HT mood color
choice
Mood color (n = 87) Mean score 95% confidence interval p value
Lower limit Upper limit
Symptom severity
Positive (n = 53) 169.23 142.13 196.32 ANOVA:
f (2,84) = 4.591; p = 0.013
Neutral (n = 26) 207.77 160.96 254.58
Negative (n = 8) 290.88 153.95 427.80
Non-colonic
Positive (n = 53) 158.85 137.02 180.68 ANOVA:
f (2,84) = 3.879; p = 0.024;
Neutral (n = 26) 158.04 122.97 193.11
Negative (n = 8) 249.13 135.06 363.19
Quality of life
Positive (n = 53) 156.34 135.85 176.83 ANOVA:
f (2,84) = 4.528; p = 0.014
Neutral (n = 26) 184.85 154.40 215.29
Negative (n = 8) 241.13 148.90 333.35
Out of a total of 156 patients, 20 were non-finishers and 49 patients chose no color at all.
Table 8 Univariate analysis relating TAS and HAD score to response to treatment
Responders
(n = 95)
No. (%)
Non-responders &
non-finishers (n = 59)
No. (%)
p value
TAS score
High 10 (10.5%) 2 (3.4%) Chi-square (2) = 9.698; p = 0.008
Medium 46 (48.4%) 18 (30.5%)
Low 39 (41.1%) 39 (66.1%)
HAD score
’HAD normal’ 26 (27.4%) 26 (44.1%) Chi-square (2) = 12.742; p = 0.002
’HAD anxious’ 52 (54.7%) 15 (25.4%)
’HAD depressed’ 17 (17.9%) 18 (30.5%)
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patients with depression seldom choose positive colors
[2], it would be of interest to explore the prevalence of
depression in individuals, irrespective of whether they
have IBS, scoring highly on the TAS scale which appears
to be strongly associated with a positive mood color
choice. With regard to actual HAD scores, patients who
c h o s ean e g a t i v ec o l o rw e r em o r el i k e l yt oh a v eh i g h e r
anxiety and depression scores. Conversely, patients who
chose a positive color to describe their mood were sig-
nificantly more likely to have lower anxiety and depres-
sion scores. This result confirms our previous findings
showing that negative colors were more likely to be cho-
sen by depressed subjects and that in most cases the
higher the depression score the more likely they are to
choose such a color [2]. Overall the mean HAD scores
fell substantially following HT and although some
patients still fell into the category of depression their
overall HAD scores had improved. Another notable
point was that the number of patients choosing a posi-
tive shade to describe their mood increased from 13 to
53 patients following HT and the number of patients
choosing a negative shade decreased from 38 to 8
patients following treatment. Mood color choice was
also seen to be significantly associated with IBS symp-
tom severity, non-colonic symptom score and quality of
life following HT.
Conclusion
Mood color choice, anxiety and a high TAS score are
independent predictors of good outcome to HT which
can be combined to strengthen their predictive value. It
may be that in the future data such as these could be
combined with our previous observations on imagery
[1,17] to give an overall score with thresholds for pre-
dicting a poor, moderate or good response to HT.
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